Marine actinobacteria: An important source of bioactive natural products

Environmental Toxicology and Pharmacology

Volumn 38, Issue 1, 2014, Pages 172-188

  Manivasagan, Panchanathan ^a   Kang, Kyong Hwa ^a   Sivakumar, Kannan ^b   Li Chan, Eunice C Y ^c   Oh, Hyun Myung ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

^b ANNAMALAI UNIVERSITY   (India)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antibiotics; Bioactive compounds; Chemical structures; Marine actinobacteria; Natural products

Indexed keywords

8 AMINO [1,4]DIAZONANE 2,5 DIONE; ABYSSOMICIN C; ACTINOFURANONE DERIVATIVE; ARENAMIDE DERIVATIVE; ARENICOLIDE DERIVATIVE; AZAMERONE; CHALCOMYCIN A; CHARTREUSIN; CYCLOMARIN A; DARYAMIDE DERIVATIVE; GLYCIAPYRROLE DERIVATIVE; GRISEORHODIN A; HIMALOMYCIN DERIVATIVE; KOMODOQUINONE A; LEUCYL 4 HYDROXYPROLINE; LUCENTAMYCIN DERIVATIVE; MECHERCHARMYCIN DERIVATIVE; NATURAL PRODUCT; PACIFICANONE DERIVATIVE; PHAEOCHROMYCIN DERIVATIVE; PIPERAZIMYCIN DERIVATIVE; POLYKETIDE; PROXIMICIN DERIVATIVE; SALINAMIDE DERIVATIVE; SALINIKETAL; SALINIPYRONE DERIVATIVE; SELINA 4(14),7(11) DIENE 8,9 DIO; TETRACENOMYCIN D; THIOCORALINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; BIOLOGICAL PRODUCT;

ACTINOBACTERIA; ACTINOMADURA; ACTINOPLANES; AMYCOLATOPSIS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CYTOTOXICITY; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; INSECTICIDAL ACTIVITY; MARINE BACTERIUM; MARINISPORA; MICROMONOSPORA; NOCARDIOPSIS; NOCARDIOPSIS LUCENTENSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SACCHAROPOLYSPORA; SALINISPORA; SALINISPORA ARENICOLA; SALINISPORA PACIFICA; STREPTOMYCES; STREPTOMYCES ACRIMYCINI; STREPTOMYCES CORCHORUSII; VERRUCOSISPORA; ANIMAL; CHEMISTRY; METABOLISM;

ACTINOBACTERIA; ANIMALS; BIOLOGICAL PRODUCTS; HUMANS;

EID: 84902982808     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2014.05.014     Document Type: Review

References (79)

1. Adinarayana G., Venkateshan M., Bapiraju V., Sujatha P., Premkumar J., Ellaiah P., Zeeck A. Cytotoxic compounds from the marine actinobacterium Streptomyces corchorusii AUBN1/71. Russ. J. Bioorg. Chem. 2006, 32:295-300.
2. Asolkar R.N., Freel K.C., Jensen P.R., Fenical W., Kondratyuk T.P., Park E.-J., Pezzuto J.M. Arenamides A-C, cytotoxic NFκB inhibitors from the marine Actinomycete Salinispora arenicola. J. Nat. Prod. 2008, 72:396-402.
3. Asolkar R.N., Jensen P.R., Kauffman C.A., Fenical W. Daryamides AC, weakly cytotoxic polyketides from a marine-derived actinomycete of the genus Streptomyces strain CNQ-085. J. Nat. Prod. 2006, 69:1756-1759.
4. Asolkar R.N., Maskey R.P., Helmke E., Laatsch H. Chalcomycin B, a new macrolide antibiotic from the marine isolate Streptomyces sp. B7064. J. Antibiot. 2002, 55:893-898.
5. Bae M., Yamada K., Ijuin Y., Tsuji T., Yazawa K., Uemura D. Aburatubolactam A, a novel inhibitor of superoxide anion generation from a marine microorganism. Heterocycl. Commun. 1996, 2:315-318.
6. Baltz R.H. Renaissance in antibacterial discovery from actinomycetes. Curr. Opin. Pharmacol. 2008, 8:557-563.
7. Bister B., Bischoff D., Stroebele M., Riedlinger J., Reicke A., Wolter F., Bull A.T., Zaehner H., Fiedler H.-P., Süssmuth R.D. Abyssomicin C-a polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway. Angew. Chem. Int. Ed. 2004, 43:2574-2576.
8. Blunt J.W., Copp B.R., Hu W.P., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2007, 24:31-86.
9. Blunt J.W., Copp B.R., Munro M.H., Northcote P.T., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2006, 23:26-78.
10. Bugni T.S., Woolery M., Kauffman C.A., Jensen P.R., Fenical W. Bohemamines from a marine-derived Streptomyces sp. J. Nat. Prod. 2006, 69:1626-1628.
11. Bull A. Bountiful oceans. Prospecting marine microbial diversity. Scr. Trends Drug Discov. 2004, 5:14-16.
12. Bull A.T., Stach J.E.M., Ward A.C., Goodfellow M. Marine actinobacteria: perspectives, challenges, future directions. Antonie Van Leeuwenhoek 2005, 87:65-79.
13. Butler M.S., Buss A.D. Natural products-the future scaffolds for novel antibiotics?. Biochem. Pharmacol. 2006, 71:919-929.
14. Cho J.Y., Kwon H.C., Williams P.G., Jensen P.R., Fenical W. Azamerone, a terpenoid phthalazinone from a marine-derived bacterium related to the genus Streptomyces (Actinomycetales). Org. Lett. 2006, 8:2471-2474.
15. Cho J.Y., Kwon H.C., Williams P.G., Kauffman C.A., Jensen P.R., Fenical W. Actinofuranones A and B, polyketides from a marine-derived bacterium related to the genus Streptomyces (Actinomycetales). J. Nat. Prod. 2006, 69:425-428.
16. Cho J.Y., Williams P.G., Kwon H.C., Jensen P.R., Fenical W. Lucentamycins AD, cytotoxic peptides from the marine-derived actinomycete Nocardiopsis lucentensis. J. Nat. Prod. 2007, 70:1321-1328.
17. Ding L., Pfoh R., Rühl S., Qin S., Laatsch H. T-muurolol sesquiterpenes from the marine Streptomyces sp. M491 and revision of the configuration of previously reported amorphanes. J. Nat. Prod. 2008, 72:99-101.
18. El-Gendy M.M., Shaaban M., Shaaban K.A., El-Bondkly A.M., Laatsch H. Essramycin: a first triazolopyrimidine antibiotic isolated from nature. J. Antibiot. 2008, 61:149-157.
19. Elyakov G.B., Stonik V.A., Kuznetsova T.A., Mikhailov V.V. From chemistry of marine natural products to marine technologies: research at the Pacific Institute of Bioorganic Chemistry. Mar. Technol. Soc. J. 1996, 30:21-28.
20. Fenical W., Jensen P.R. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2006, 2:666-673.
21. Fiedler H.P., Bruntner C., Bull A.T., Ward A.C., Goodfellow M., Potterat O., Puder C., Mihm G. Marine actinomycetes as a source of novel secondary metabolites. Antonie Van Leeuwenhoek 2005, 87:37-42.
22. Fiedler H.P., Bruntner C., Riedlinger J., Bull A.T., Knutsen G., Goodfellow M., Jones A., Maldonado L., Pathom-Aree W., Beil W. Proximicin A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora. J. Antibiot. 2008, 61:158-163.
23. Hameş-Kocabaş E., Uzel A. Isolation strategies of marine-derived actinomycetes from sponge and sediment samples. J. Microbiol. Methods 2012, 88:342-347.
24. Hardt I.H., Jensen P.R., Fenical W. Neomarinone, and new cytotoxic marinone derivatives, produced by a marine filamentous bacterium (actinomycetales). Tetrahedron Lett. 2000, 41:2073-2076.
25. Hayakawa Y., Shirasaki S., Shiba S., Kawasaki T., Matsuo Y., Adachi K., Shizuri Y. Piericidins C7 and C8, new cytotoxic antibiotics produced by a marine Streptomyces sp. J. Antibiot. 2007, 60:196-200.
26. Hernández I.L., Macedo M.L., Berlinck R.G., Ferreira A.G., Godinho M.J. Dipeptide metabolites from the marine derived bacterium Streptomyces acrymicini. J. Braz. Chem. Soc. 2004, 15:441-444.
27. Hohmann C., Schneider K., Bruntner C., Irran E., Nicholson G., Bull A.T., Jones A.L., Brown R., Stach J.E., Goodfellow M. Caboxamycin, a new antibiotic of the benzoxazole family produced by the deep-sea strain Streptomyces sp. NTK 937. J. Antibiot. 2009, 62:99-104.
28. Hughes C.C., MacMillan J.B., Gaudêncio S.P., Jensen P.R., Fenical W. The ammosamides: structures of cell cycle modulators from a marine-derived Streptomyces species. Angew. Chem. Int. Ed. 2009, 48:725-727.
29. Hughes C.C., Prieto-Davo A., Jensen P.R., Fenical W. The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. Org. Lett. 2008, 10:629-631.
30. Imada C. Enzyme inhibitors and other bioactive compounds from marine actinomycetes. Antonie Van Leeuwenhoek 2005, 87:59-63.
31. Itoh T., Kinoshita M., Aoki S., Kobayashi M. Komodoquinone A, a novel neuritogenic anthracycline, from marine Streptomyces sp. KS3. J. Nat. Prod. 2003, 66:1373-1377.
32. Itoh T., Kinoshita M., Wei H., Kobayashi M. Stereostructure of komodoquinone A, a neuritogenic anthracycline, from marine Streptomyces sp. KS3. Chem. Pharm. Bull. 2003, 51:1402-1404.
33. Jae S.H., Jeong H.S., Lee H.-S., Park S.-K., Kim H.M., Kwon H.J. Isolation and structure determination of streptochlorin, an antiproliferative agent from a marine-derived Streptomyces sp. 04DH110. J. Microbiol. Biotechnol. 2007, 17:1403-1406.
34. Jensen P.R., Gontang E., Mafnas C., Mincer T.J., Fenical W. Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ. Microbiol. 2005, 7:1039-1048.
35. Jensen P.R., Williams P.G., Oh D.C., Zeigler L., Fenical W. Species-specific secondary metabolite production in marine actinomycetes of the genus Salinispora. Appl. Environ. Microbiol. 2007, 73:1146-1152.
36. Jeong S.-Y., Shin H.J., Kim T.S., Lee H.-S., Park S.-K., Kim H.M. Streptokordin, a new cytotoxic compound of the methylpyridine class from a marine-derived Streptomyces sp. KORDI-3238. J. Antibiot. 2006, 59:234-240.
37. Kanoh K., Matsuo Y., Adachi K., Imagawa H., Nishizawa M., Shizuri Y. Mechercharmycins A and B, cytotoxic substances from marine-derived Thermoactinomyces sp. YM3-251. J. Antibiot. 2005, 58:289-292.
38. Lam K.S. Discovery of novel metabolites from marine actinomycetes. Curr. Opin. Microbiol. 2006, 9:245-251.
39. Li A., Piel J. A gene cluster from a marine Streptomyces encoding the biosynthesis of the aromatic spiroketal polyketide Griseorhodin A. Chem. Biol. 2002, 9:1017-1026.
40. Li D.-H., Zhu T.-J., Liu H.-B., Fang Y.-C., Gu Q.-Q., Zhu W.-M. Four butenolides are novel cytotoxic compounds isolated from the marine-derived bacterium, Streptoverticillium luteoverticillatum 11014. Arch. Pharm. Res. 2006, 29:624-626.
41. Li F., Maskey R.P., Qin S., Sattler I., Fiebig H.H., Maier A., Zeeck A., Laatsch H. Chinikomycins A and B: isolation, structure elucidation, and biological activity of novel antibiotics from a marine Streptomyces sp. isolate M045. J. Nat. Prod. 2005, 68:349-353.
42. Li J., Lu C.-H., Zhao B.-B., Zheng Z.-H., Shen Y.-M. Phaeochromycins F-H, three new polyketide metabolites from Streptomyces sp. DSS-18. Beilstein J. Org. Chem. 2008, 4:46-50.
43. 2039-2. Arch. Pharm. Res. 2007, 30:270-274.
44. Lu Y., Dong X., Liu S., Bie X. Characterization and identification of a novel marine Streptomyces sp. produced antibacterial substance. Mar. Biotechnol. 2009, 11:717-724.
45. Macherla V.R., Liu J., Bellows C., Teisan S., Nicholson B., Lam K.S., Barbara C. Glaciapyrroles A, B, and C, pyrrolosesquiterpenes from a Streptomyces sp. isolated from an Alaskan marine sediment. J. Nat. Prod. 2005, 68:780-783.
46. Maldonado L.A., Stach J.E., Pathom-aree W., Ward A.C., Bull A.T., Goodfellow M. Diversity of cultivable actinobacteria in geographically widespread marine sediments. Antonie Van Leeuwenhoek 2005, 87:11-18.
47. Manivasagan P., Venkatesan J., Sivakumar K., Kim S.-K. Marine actinobacterial metabolites: current status and future perspectives. Microbiol. Res. 2013, 168:311-332.
48. Manivasagan P., Venkatesan J., Sivakumar K., Kim S.-K. Pharmaceutically active secondary metabolites of marine actinobacteria. Microbiol. Res. 2014, 169(26):262-278.
49. Maskey R.P., Helmke E., Kayser O., Fiebig H.H., Maier A., Busche A., Laatsch H. Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry. J. Antibiot. 2004, 57:771-779.
50. Maskey R.P., Helmke E., Laatsch H. Himalomycin A and B: isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate. J. Antibiot. 2003, 56:942-949.
51. Miller E.D., Kauffman C.A., Jensen P.R., Fenical W. Piperazimycins: cytotoxic hexadepsipeptides from a marine-derived bacterium of the genus Streptomyces. J. Org. Chem. 2007, 72:323-330.
52. Mincer T.J., Fenical W., Jensen P.R. Culture-dependent and culture-independent diversity within the obligate marine actinomycete genus Salinispora. Appl. Environ. Microbiol. 2005, 71:7019-7028.
53. Mincer T.J., Jensen P.R., Kauffman C.A., Fenical W. Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments. Appl. Environ. Microbiol. 2002, 68:5005-5011.
54. Mitchell S.S., Nicholson B., Teisan S., Lam K.S., Barbara C. Aureoverticillactam, a novel 22-atom macrocyclic lactam from the marine actinomycete Streptomyces aureoverticillatus. J. Nat. Prod. 2004, 67:1400-1402.
55. Moore B.S., Trischman J.A., Seng D., Kho D., Jensen P.R., Fenical W. Salinamides, antiinflammatory depsipeptides from a marine streptomycete. J. Org. Chem. 1999, 64:1145-1150.
56. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70:461-477.
57. Oh D.-C., Gontang E.A., Kauffman C.A., Jensen P.R., Fenical W. Salinipyrones and pacificanones, mixed-precursor polyketides from the marine actinomycete Salinispora pacifica. J. Nat. Prod. 2008, 71:570-575.
58. Palaniappan S., Panchanathan M., Packiyaraj V., Kannan S., Shanmugam S., Subramaniam P., Viswanathan M., Shanmugam V., Balasubramanian T. Antibacterial and brine shrimp lethality effect of marine actinobacterium Streptomyces sp. CAS72 against human pathogenic bacteria. Asian Pac. J. Trop. Dis. 2013, 3:286-293.
59. Perez B.J., Canedo L., Fernández P.J., Silva E.M. Thiocoraline, a novel depsipeptide with antitumor activity produced by a marine Micromonospora. II. Physico-chemical properties and structure determination. J. Antibiot. 1997, 50:738-741.
60. Rath J.-P., Kinast S., Maier M.E. Synthesis of the fully functionalized core structure of the antibiotic abyssomicin C. Org. Lett. 2005, 7:3089-3092.
61. Renner M.K., Shen Y.-C., Cheng X.-C., Jensen P.R., Frankmoelle W., Kauffman C.A., Fenical W., Lobkovsky E., Clardy J. Cyclomarins AC, new antiinflammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.). J. Am. Chem. Soc. 1999, 121:11273-11276.
62. Riedlinger J., Reicke A., Zähner H., Krismer B., Bull A.T., Maldonado L.A., Ward A.C., Goodfellow M., Bister B., Bischoff D. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiot. 2004, 57:271-279.
63. Romero F., Espliego F., Pérez B.J., García d.Q.T., Grávalos D., De la Calle F., Fernández-Puentes J.L. Thiocoraline, a new depsipeptide with antitumor activity produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation, and biological activities. J. Antibiot. 1997, 50:734-737.
64. Sánchez López J.M., Martínez Insua M., Pérez Baz J., Fernández Puentes J.L., Cañedo Hernández L.M. New cytotoxic indolic metabolites from a marine Streptomyces. J. Nat. Prod. 2003, 66:863-864.
65. Schneider K., Keller S., Wolter F.E., Röglin L., Beil W., Seitz O., Nicholson G., Bruntner C., Riedlinger J., Fiedler H.-P. Proximicins A, B, and C-antitumor furan analogues of netropsin from the marine actinomycete Verrucosispora induce upregulation of p53 and the cyclin kinase inhibitor p21. Angew. Chem. Int. Ed. 2008, 47:3258-3261.
66. Schumacher R.W., Talmage S.C., Miller S.A., Sarris K.E., Davidson B.S., Goldberg A. Isolation and structure determination of an antimicrobial ester from a marine sediment-derived bacterium. J. Nat. Prod. 2003, 66:1291-1293.
67. Sobolevskaya M., Kuznetsova T. Biologically active metabolites of marine actinobacteria. Russ. J. Bioorg. Chem. 2010, 36:560-573.
68. Stach E., Bull A.T. Estimating and comparing the diversity of marine actinobacteria. Antonie Van Leeuwenhoek 2005, 87:3-9.
69. Staunton J., Weissman K.J. Polyketide biosynthesis: a millennium review. Nat. Prod. Rep. 2001, 18:380-416.
70. Takahashi A., Ikeda D., Nakamura H., Naganawa H., Kurasawa S., Okami Y., Takeuchi T. Altemicidin, a new acaricidal and antitumor substance. II. Structure determination. J. Antibiot. 1989, 42:1562-1566.
71. Takahashi A., Kurasawa S., Ikeda D., Okami Y., Takeuchi T. Altemicidin, a new acaricidal and antitumor substance. I. Taxonomy, fermentation, isolation and physico-chemical and biological properties. J. Antibiot. 1989, 42:1556-1561.
72. Wagner-Döbler I., Beil W., Lang S., Meiners M., Laatsch H. Integrated approach to explore the potential of marine microorganisms for the production of bioactive metabolites, tools and applications of biochemical engineering science. Adv. Biochem. Eng. Biotechnol. 2002, 74:207-238.
73. Weber T., Welzel K., Pelzer S., Vente A., Wohlleben W. Exploiting the genetic potential of polyketide producing streptomycetes. J. Biotechnol. 2003, 106:221-232.
74. Williams P.G., Asolkar R.N., Kondratyuk T., Pezzuto J.M., Jensen P.R., Fenical W. Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola. J. Nat. Prod. 2007, 70:83-88.
75. Williams P.G., Miller E.D., Asolkar R.N., Jensen P.R., Fenical W. Arenicolides AC, 26-membered ring macrolides from the marine actinomycete Salinispora arenicola. J. Org. Chem. 2007, 72:5025-5034.
76. Wu S.J., Fotso S., Li F., Qin S., Kelter G., Fiebig H.H., Laatsch H. N-Carboxamido-staurosporine and Selina-4 (14), 7 (11)-diene-8, 9-diol, new metabolites from a marine Streptomyces sp. J. Antibiot. 2006, 59:331-337.
77. Wu S.J., Fotso S., Li F., Qin S., Laatsch H. Amorphane sesquiterpenes from a marine Streptomyces sp. J. Nat. Prod. 2007, 70:304-306.
78. Xu Z., Jakobi K., Welzel K., Hertweck C. Biosynthesis of the antitumor agent Chartreusin involves the oxidative rearrangement of an anthracyclic polyketide. Chem. Biol. 2005, 12:579-588.
79. Yamada K., Kuramoto M., Uemura D. Aburatubolactams and zoanthamines, naturally occurring bioactive alkaloids. Recent Res. Dev. Pure Appl. Chem. 1999, 3:245-254.